# Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme' Hypofractionation

> **NCT06894628** · — · RECRUITING · sponsor: **Regina Elena Cancer Institute** · enrollment: 103 (estimated)

## Conditions studied

- Prostatic Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06894628
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-04
- **Primary completion:** 2027-11-04
- **Final completion:** 2027-11-04
- **Target enrollment:** 103 (ESTIMATED)
- **Last updated:** 2025-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06894628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06894628, "Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme' Hypofractionation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06894628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*